P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

• R. Cordoba,
• L. Falchi,
• T. Phillips,
• S. de Vos,
• M. Nijland,
• F. Offner,
• I. Bykhovski,
• J. Wu,
• L. Wang,
• A. Rana,
• P. Abrisqueta

Affiliations

R. Cordoba

1 Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain

L. Falchi

2 Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York

T. Phillips

3 University of Michigan Comprehensive Cancer Center, Ann Arbor

S. de Vos

4 Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, United States of America

M. Nijland

5 University Medical Center Groningen and University of Groningen, Groningen, Netherlands

F. Offner

6 Universitair Ziekenhuis Gent, Ghent, Belgium

I. Bykhovski

7 Genmab, Princeton

J. Wu

8 AbbVie, North Chicago, United States of America

L. Wang

7 Genmab, Princeton

A. Rana

7 Genmab, Princeton

P. Abrisqueta

9 Hospital Universitario Vall d’Hebron, Barcelona, Spain